Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announced that Roche received U.S. Food and Drug Administration (FDA) approval for OCREVUS ZUNOVOâ„¢ (ocrelizumab and hyaluronidase-ocsq) with ...
Two recent surveys of consumers show record lows in confidence of the safety of the U.S. food supply. In a Gallup poll, 28 percent of survey respondents do not have much confidence, and 14 percent ...
Sunday's matchup in New Orleans could serve as a confidence-infusing springboard for the Eagles defense -- or, it could deepen doubts. Philadelphia Phillies (92-62, first in the NL East) vs. New ...